Free Trial

Amneal Pharmaceuticals (AMRX) SEC Filings & 10K Form

Amneal Pharmaceuticals logo
$7.74 +0.08 (+1.04%)
Closing price 05/1/2025 04:00 PM Eastern
Extended Trading
$7.74 0.00 (0.00%)
As of 04:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Amneal Pharmaceuticals SEC Filings

DateFilerForm TypeView
04/02/2025
3:12 PM
Amneal Pharmaceuticals (Issuer)
Patel Gautam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2025
3:16 PM
Amneal Pharmaceuticals (Filer)
Form DEFA14A
03/17/2025
3:45 PM
Amneal Pharmaceuticals (Subject)
Patel Tushar Bhikhubhai (Filed by)
Form SCHEDULE 13D/A
03/14/2025
6:32 PM
Amneal Pharmaceuticals (Subject)
Patel Tushar Bhikhubhai (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/12/2025
3:11 PM
Amneal Pharmaceuticals (Issuer)
BUCHI J KEVIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
3:16 PM
Alva Emily Peterson (Reporting)
Amneal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
3:17 PM
Amneal Pharmaceuticals (Issuer)
Konidaris Tasos (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
3:17 PM
Amneal Pharmaceuticals (Issuer)
Daly Jason B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
3:18 PM
Amneal Pharmaceuticals (Issuer)
BOYER ANDREW S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
7:18 PM
Amneal Pharmaceuticals (Issuer)
BOYER ANDREW S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
7:21 PM
Amneal Pharmaceuticals (Issuer)
Daly Jason B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
6:53 PM
Amneal Pharmaceuticals (Issuer)
Konidaris Tasos (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
6:31 PM
Amneal Pharmaceuticals (Issuer)
Patel Chintu (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
6:33 PM
Amneal Pharmaceuticals (Issuer)
Patel Chirag K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
6:11 PM
Amneal Pharmaceuticals (Issuer)
Shah Nikita (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
6:12 PM
Amneal Pharmaceuticals (Issuer)
Patel Gautam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
9:00 AM
Amneal Pharmaceuticals (Subject)
Konidaris Tasos (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2025
6:03 PM
Amneal Pharmaceuticals (Issuer)
BOYER ANDREW S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
5:58 PM
Amneal Pharmaceuticals (Issuer)
Shah Nikita (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
5:59 PM
Amneal Pharmaceuticals (Issuer)
Konidaris Tasos (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2025
5:13 AM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/10/2025
7:59 AM
Amneal Pharmaceuticals (Subject)
UBS Group AG (Filed by)
Form SCHEDULE 13G/A
02/05/2025
3:31 PM
Amneal Pharmaceuticals (Issuer)
Patel Gautam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
4:49 PM
Amneal Pharmaceuticals (Subject)
Patel Dipan (Filed by)
Form SCHEDULE 13D/A
01/15/2025
5:14 AM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
3:25 PM
Amneal Pharmaceuticals (Issuer)
Patel Gautam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
3:22 PM
Amneal Pharmaceuticals (Issuer)
Patel Gautam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2025
3:48 PM
Amneal Pharmaceuticals (Subject)
Patel Gautam (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/26/2024
3:41 PM
Amneal Pharmaceuticals (Issuer)
Kiely John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
3:26 PM
Amneal Pharmaceuticals (Issuer)
Autor Deborah M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
3:38 PM
Amneal Pharmaceuticals (Issuer)
Daly Jason B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
9:39 AM
Amneal Pharmaceuticals (Subject)
Kiely John (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/21/2024
1:01 PM
Amneal Pharmaceuticals (Subject)
Autor Deborah M. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/15/2024
12:49 PM
Amneal Pharmaceuticals (Subject)
Daly Jason B. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/08/2024
5:08 AM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2024
5:51 PM
Amneal Pharmaceuticals (Subject)
Patel Chirag K. (Filed by)
Form SC 13D/A
10/30/2024
10:04 AM
Amneal Pharmaceuticals (Subject)
UBS Group AG (Filed by)
Form SCHEDULE 13G
10/01/2024
6:10 AM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
2:12 PM
Amneal Pharmaceuticals (Subject)
Shah Nikita (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2024
10:04 AM
Amneal Pharmaceuticals (Subject)
Shah Nikita (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/09/2024
3:27 PM
Amneal Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
Trump Orders 'National Digital Asset Stockpile' (Ad)

Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what could be the biggest wealth opportunity since Bitcoin's early days.

Click Here to get our complete analysis on why this lending platform is our #1 "buy the dip" opportu
08/09/2024
5:14 AM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2024
2:13 PM
Amneal Pharmaceuticals (Subject)
Autor Deborah M. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/14/2024
3:38 PM
Amneal Pharmaceuticals (Issuer)
Patel Gautam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
3:39 PM
Amneal Pharmaceuticals (Issuer)
Yanai Shlomo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
3:40 PM
Amneal Pharmaceuticals (Issuer)
Nark Ted C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
3:41 PM
Amneal Pharmaceuticals (Issuer)
BUCHI J KEVIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
3:42 PM
Amneal Pharmaceuticals (Issuer)
George Jeffrey P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
3:43 PM
Amneal Pharmaceuticals (Issuer)
Kiely John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
3:44 PM
Amneal Pharmaceuticals (Issuer)
MEISTER PAUL M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
3:45 PM
Amneal Pharmaceuticals (Issuer)
Autor Deborah M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
3:45 PM
Alva Emily Peterson (Reporting)
Amneal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
3:46 PM
Amneal Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2024
3:18 PM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2024
4:19 PM
Amneal Pharmaceuticals (Issuer)
Autor Deborah M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2024
4:23 PM
Amneal Pharmaceuticals (Issuer)
BUCHI J KEVIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2024
4:28 PM
Amneal Pharmaceuticals (Issuer)
George Jeffrey P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2024
4:31 PM
Amneal Pharmaceuticals (Issuer)
Kiely John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2024
4:34 PM
Amneal Pharmaceuticals (Issuer)
Nark Ted C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2024
4:35 PM
Amneal Pharmaceuticals (Issuer)
Patel Gautam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2024
4:38 PM
Amneal Pharmaceuticals (Issuer)
Yanai Shlomo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
5:14 AM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:AMRX) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners